Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Altered Gray Matter Structure and White Matter Microstructure in Patients with Congenital Adrenal Hyperplasia: Relevance for Working Memory Performance.

Van't Westeinde A, Karlsson L, Thomsen Sandberg M, Nordenström A, Padilla N, Lajic S.

Cereb Cortex. 2019 Dec 10. pii: bhz274. doi: 10.1093/cercor/bhz274. [Epub ahead of print]

PMID:
31819952
2.

Carriers of a Classic CYP21A2 Mutation Have Reduced Mortality: A Population-Based National Cohort Study.

Nordenström A, Svensson J, Lajic S, Frisén L, Nordenskjöld A, Norrby C, Almqvist C, Falhammar H.

J Clin Endocrinol Metab. 2019 Dec 1;104(12):6148-6154. doi: 10.1210/jc.2019-01199.

PMID:
31393570
3.

Novel non-classic CYP21A2 variants, including combined alleles, identified in patients with congenital adrenal hyperplasia.

Karlsson L, de Paula Michelatto D, Lusa ALG, D'Almeida Mgnani Silva C, Östberg LJ, Persson B, Guerra-Júnior G, Valente de Lemos-Marini SH, Baldazzi L, Menabó S, Balsamo A, Greggio NA, Palandi de Mello M, Barbaro M, Lajic S.

Clin Biochem. 2019 Nov;73:50-56. doi: 10.1016/j.clinbiochem.2019.07.009. Epub 2019 Jul 22.

PMID:
31344365
4.

Epigenetic Alterations Associated With Early Prenatal Dexamethasone Treatment.

Karlsson L, Barbaro M, Ewing E, Gomez-Cabrero D, Lajic S.

J Endocr Soc. 2018 Dec 12;3(1):250-263. doi: 10.1210/js.2018-00377. eCollection 2019 Jan 1.

5.

Retraction notice to"Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish adolescents at risk of CAH" [Hormones and Behavior 85C (2016) 5-11].

Wallensteen L, Zimmermann M, Sandberg MT, Gezelius A, Nordenström A, Hirvikoski T, Lajic S.

Horm Behav. 2018 Jul;103:140. doi: 10.1016/j.yhbeh.2018.06.009. No abstract available.

PMID:
30072011
6.

Prenatal Treatment of Congenital Adrenal Hyperplasia: Long-Term Effects of Excess Glucocorticoid Exposure.

Lajic S, Karlsson L, Nordenström A.

Horm Res Paediatr. 2018;89(5):362-371. doi: 10.1159/000485100. Epub 2018 May 9. Review.

PMID:
29742490
7.

Prenatal dexamethasone treatment in the context of at risk CAH pregnancies: Long-term behavioral and cognitive outcome.

Karlsson L, Nordenström A, Hirvikoski T, Lajic S.

Psychoneuroendocrinology. 2018 May;91:68-74. doi: 10.1016/j.psyneuen.2018.02.033. Epub 2018 Mar 1.

PMID:
29529521
8.

Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish children and adolescents at risk of congenital adrenal hyperplasia.

Wallensteen L, Karlsson L, Messina V, Gezelius A, Sandberg MT, Nordenström A, Hirvikoski T, Lajic S.

Horm Behav. 2018 Feb;98:219-224. doi: 10.1016/j.yhbeh.2017.11.004. Epub 2018 Feb 6.

PMID:
29410007
9.

Cognitive impairment in adolescents and adults with congenital adrenal hyperplasia.

Karlsson L, Gezelius A, Nordenström A, Hirvikoski T, Lajic S.

Clin Endocrinol (Oxf). 2017 Dec;87(6):651-659. doi: 10.1111/cen.13441. Epub 2017 Aug 31.

PMID:
28771762
10.

Functional and Structural Consequences of Nine CYP21A2 Mutations Ranging from Very Mild to Severe Effects.

de Paula Michelatto D, Karlsson L, Lusa AL, Silva CD, Östberg LJ, Persson B, Guerra-Júnior G, de Lemos-Marini SH, Barbaro M, de Mello MP, Lajic S.

Int J Endocrinol. 2016;2016:4209670. Epub 2016 Sep 19.

11.

Sex-Dimorphic Effects of Prenatal Treatment With Dexamethasone.

Wallensteen L, Zimmermann M, Thomsen Sandberg M, Gezelius A, Nordenström A, Hirvikoski T, Lajic S.

J Clin Endocrinol Metab. 2016 Oct;101(10):3838-3846. Epub 2016 Aug 2. Erratum in: J Clin Endocrinol Metab. 2018 Feb 1;103(2):700.

PMID:
27482827
12.

RETRACTED: Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish adolescents at risk of CAH.

Wallensteen L, Zimmermann M, Sandberg MT, Gezelius A, Nordenström A, Hirvikoski T, Lajic S.

Horm Behav. 2016 Sep;85:5-11. doi: 10.1016/j.yhbeh.2016.06.011. Epub 2016 Jun 30. Retraction in: 10.1016/j.yhbeh.2016.06.011. Horm Behav. 2018 Jul;103:140.

PMID:
27373757
13.

In vitro functional studies of rare CYP21A2 mutations and establishment of an activity gradient for nonclassic mutations improve phenotype predictions in congenital adrenal hyperplasia.

Barbaro M, Soardi FC, Östberg LJ, Persson B, de Mello MP, Wedell A, Lajic S.

Clin Endocrinol (Oxf). 2015 Jan;82(1):37-44. doi: 10.1111/cen.12526. Epub 2014 Jul 7.

PMID:
24953648
14.

Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint.

Hirvikoski T, Nordenström A, Wedell A, Ritzén M, Lajic S.

J Clin Endocrinol Metab. 2012 Jun;97(6):1881-3. doi: 10.1210/jc.2012-1222. No abstract available.

PMID:
22466333
15.

Functional studies of CYP21A2 mutants complement structural and clinical predictions of disease severity in CAH.

Barbaro M, Soardi FC, de Mello MP, Wedell A, Lajic S.

Clin Endocrinol (Oxf). 2012 May;76(5):766-8. doi: 10.1111/j.1365-2265.2011.04275.x. No abstract available.

PMID:
22040027
16.

Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia--a pilot study.

Hirvikoski T, Lindholm T, Lajic S, Nordenström A.

Acta Paediatr. 2011 Sep;100(9):e112-9. doi: 10.1111/j.1651-2227.2011.02260.x. Epub 2011 Apr 8.

PMID:
21388450
17.

Long-term outcome of prenatal dexamethasone treatment of 21-hydroxylase deficiency.

Lajic S, Nordenström A, Hirvikoski T.

Endocr Dev. 2011;20:96-105. doi: 10.1159/000321228. Epub 2010 Dec 16. Review.

PMID:
21164263
18.

Deficient cardiovascular stress reactivity predicts poor executive functions in adults with attention-deficit/hyperactivity disorder.

Hirvikoski T, Olsson EM, Nordenstrom A, Lindholm T, Nordstrom AL, Lajic S.

J Clin Exp Neuropsychol. 2011 Jan;33(1):63-73. doi: 10.1080/13803395.2010.493145. Epub 2010 Jul 5.

PMID:
20603741
19.

Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation.

Rivero-Müller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, Jonas K, Rahman N, Ji TH, Huhtaniemi I.

Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2319-24. doi: 10.1073/pnas.0906695106. Epub 2010 Jan 11.

20.

High self-perceived stress and many stressors, but normal diurnal cortisol rhythm, in adults with ADHD (attention-deficit/hyperactivity disorder).

Hirvikoski T, Lindholm T, Nordenström A, Nordström AL, Lajic S.

Horm Behav. 2009 Mar;55(3):418-24. doi: 10.1016/j.yhbeh.2008.12.004. Epub 2008 Dec 31.

PMID:
19162030
21.

Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems?

Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Lajic S.

Eur J Endocrinol. 2008 Sep;159(3):309-16. doi: 10.1530/EJE-08-0280. Epub 2008 Jun 25.

PMID:
18579553
22.

Long-term outcome of prenatal treatment of congenital adrenal hyperplasia.

Lajic S, Nordenström A, Hirvikoski T.

Endocr Dev. 2008;13:82-98. doi: 10.1159/000134827. Review.

PMID:
18493135
23.

Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in Brazilian and Scandinavian patients.

Soardi FC, Barbaro M, Lau IF, Lemos-Marini SH, Baptista MT, Guerra-Junior G, Wedell A, Lajic S, de Mello MP.

J Clin Endocrinol Metab. 2008 Jun;93(6):2416-20. doi: 10.1210/jc.2007-2594. Epub 2008 Apr 1.

PMID:
18381579
24.
25.

Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone.

Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Wedell A, Lajic S.

J Clin Endocrinol Metab. 2007 Feb;92(2):542-8. Epub 2006 Dec 5.

PMID:
17148562
26.

Characterization of novel missense mutations in CYP21 causing congenital adrenal hyperplasia.

Robins T, Bellanne-Chantelot C, Barbaro M, Cabrol S, Wedell A, Lajic S.

J Mol Med (Berl). 2007 Mar;85(3):247-55. Epub 2006 Nov 21.

PMID:
17119906
27.

Functional studies of two novel and two rare mutations in the 21-hydroxylase gene.

Barbaro M, Baldazzi L, Balsamo A, Lajic S, Robins T, Barp L, Pirazzoli P, Cacciari E, Cicognani A, Wedell A.

J Mol Med (Berl). 2006 Jun;84(6):521-8. Epub 2006 Mar 16.

PMID:
16541276
28.

Not all amino acid substitutions of the common cluster E6 mutation in CYP21 cause congenital adrenal hyperplasia.

Robins T, Barbaro M, Lajic S, Wedell A.

J Clin Endocrinol Metab. 2005 Apr;90(4):2148-53. Epub 2004 Dec 28.

PMID:
15623806
29.

Prenatal treatment of congenital adrenal hyperplasia.

Lajic S, Nordenström A, Ritzén EM, Wedell A.

Eur J Endocrinol. 2004 Nov;151 Suppl 3:U63-9. Review.

PMID:
15554888
30.

Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia.

Barbaro M, Lajic S, Baldazzi L, Balsamo A, Pirazzoli P, Cicognani A, Wedell A, Cacciari E.

J Clin Endocrinol Metab. 2004 May;89(5):2402-7.

PMID:
15126570
31.

Novel mutations in CYP21 detected in individuals with hyperandrogenism.

Lajić S, Clauin S, Robins T, Vexiau P, Blanché H, Bellanne-Chantelot C, Wedell A.

J Clin Endocrinol Metab. 2002 Jun;87(6):2824-9.

PMID:
12050257
32.

CYP21 mutations in simple virilizing congenital adrenal hyperplasia.

Lajić S, Robins T, Krone N, Schwarz HP, Wedell A.

J Mol Med (Berl). 2001 Oct;79(10):581-6.

PMID:
11692155
33.

How can molecular biology contribute to the management of congenital adrenal hyperplasia?

Ritzén EM, Lajic S, Wedell A.

Horm Res. 2000;53 Suppl 1:34-7. Review.

PMID:
10895040
34.

Effects of missense mutations and deletions on membrane anchoring and enzyme function of human steroid 21-hydroxylase (P450c21).

Lajic S, Nikoshkov A, Holst M, Wedell A.

Biochem Biophys Res Commun. 1999 Apr 13;257(2):384-90.

PMID:
10198222
35.
36.

Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia.

Lajic S, Wedell A, Bui TH, Ritzén EM, Holst M.

J Clin Endocrinol Metab. 1998 Nov;83(11):3872-80.

PMID:
9814461
37.

Naturally occurring mutants of human steroid 21-hydroxylase (P450c21) pinpoint residues important for enzyme activity and stability.

Nikoshkov A, Lajic S, Vlamis-Gardikas A, Tranebjaerg L, Holst M, Wedell A, Luthman H.

J Biol Chem. 1998 Mar 13;273(11):6163-5.

38.

[Prenatal diagnosis and treatment of adrenogenital syndrome. Prevent virilization of female fetuses].

Lajic S, Bui TH, Holst M, Ritzén M, Wedell A.

Lakartidningen. 1997 Dec 10;94(50):4781-6. Review. Swedish.

PMID:
9445959
39.

A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction.

Lajic S, Levo A, Nikoshkov A, Lundberg Y, Partanen J, Wedell A.

Hum Genet. 1997 Jun;99(6):704-9.

PMID:
9187661
40.

Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency.

Nikoshkov A, Lajic S, Holst M, Wedell A, Luthman H.

J Clin Endocrinol Metab. 1997 Jan;82(1):194-9.

PMID:
8989258
41.
42.
43.

Supplemental Content

Support Center